(Q44124046)

English

Effect of urate-lowering therapy on the velocity of size reduction of tophi in chronic gout

scientific article

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

Effect of urate-lowering therapy on the velocity of size reduction of tophi in chronic gout (English)

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

0 references

Fernando Perez-Ruiz

1

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

author name string

Marcelo Calabozo

2

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

Jose I Pijoan

3

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

Ana M Herrero-Beites

4

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

Ana Ruibal

5

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

publication date

1 August 2002

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

Arthritis & Rheumatology

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

47

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

4

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

356-360

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

Milestones in the treatment of gout

1 reference

https://api.crossref.org/works/10.1002%2FART.10511

21 January 2018

Orderly arrayed deposit of urate crystals in gout suggest epitaxial formation

1 reference

https://api.crossref.org/works/10.1002%2FART.10511

21 January 2018

Management of gout

1 reference

https://api.crossref.org/works/10.1002%2FART.10511

21 January 2018

The management of gout

1 reference

https://api.crossref.org/works/10.1002%2FART.10511

21 January 2018

Crystal-induced arthritis: an overview

1 reference

https://api.crossref.org/works/10.1002%2FART.10511

21 January 2018

How well have diagnostic tests and therapies for gout been evaluated?

1 reference

https://api.crossref.org/works/10.1002%2FART.10511

21 January 2018

Severe allopurinol toxicity. Description and guidelines for prevention in patients with renal insufficiency

1 reference

https://api.crossref.org/works/10.1002%2FART.10511

21 January 2018

Allopurinol and gouty hyperuricemia. Efficacy of a single daily dose.

1 reference

https://api.crossref.org/works/10.1002%2FART.10511

21 January 2018

Effects of pyrazinamide, probenecid, and benzbromarone on renal excretion of oxypurinol

1 reference

https://api.crossref.org/works/10.1002%2FART.10511

21 January 2018

Studies of urate crystallisation in relation to gout

1 reference

https://api.crossref.org/works/10.1002%2FART.10511

21 January 2018

Benzbromarone therapy in hyperuricaemia; comparison with allopurinol and probenecid

1 reference

https://api.crossref.org/works/10.1002%2FART.10511

21 January 2018

Studies of uric acid pool size and turnover rate

1 reference

https://api.crossref.org/works/10.1002%2FART.10511

21 January 2018

Identifiers

10.1002/ART.10511

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44124046&oldid=2106830812"